B precursor acute lymphoblastic leukemia third complementarity‐determining regions predominantly represent an unbiased recombination repertoire: Leukemic transformation frequently occurs in fetal life
- 1 April 1994
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 24 (4) , 900-908
- https://doi.org/10.1002/eji.1830240418
Abstract
To determine whether the ALL (acute lymphoblastic leukemia) CDR3 (third complementarity-determining region) repertoire represents the recombination repertoire, or shows evidence of selectional processes inherent to normal B cell differentiation or malignant transformation, we analyzed 68 ALL CDR3 regions and included 127 previously published sequences in the analyses. We found no evidence of selection prior to malignant transformation as recombination was random with 1/3 “in frame” and 2/3 “out of frame” joinings and usage of all three D reading frames was observed. D and JH gene segments were predominantly umutated which allowed a detailed analysis of gene usage and rearrangement characteristics. JH4 and JH6 usage (both 32.2%) was significantly different (p = 0.005) from that observed in peripheral B lymphocytes. D gene family usage roughly represented D gene family size with the exception of the DXP and DA/K family which were over- and underrepresented (p = 0.05), respectively. D-D fusions were found in 26.2% of CDR3 regions. If less stringent criteria were applied DIR homology was found in 40/65 sequences, suggesting the frequent involvement of DIR gene segments in human CDR3 formation. The rearranged D genes were evenly distributed over the D locus, suggesting that D recombination is a predominantly random process, independent of physical location at the locus. Also, there was no correlation between JH gene usge and physical location of the rearranged D gene segment, which excludes a major contribution of the DJH replacement recombination mechanism. In 36.1% of CDR3 regions N-nucleotides at the DJH junction were absent. This frequency is higher than observed for peripheral B lymphocytes. It is suggested that for a number of ALL the initial transformational event took place in early fetal life. We conclude that ALL CDR3 sequences show no evidence of selection prior to malignant transformation, nor of extensive changes subsequent to malignant transformation.Keywords
This publication has 49 references indexed in Scilit:
- Mechanisms that generate human immunoglobulin diversity operate from the 8th week of gestation in fetal liverEuropean Journal of Immunology, 1993
- Predominance of fetal type DJH joining in young children with B precursor lymphoblastic leukemia as evidence for an in utero transforming event.The Journal of Experimental Medicine, 1992
- Preferential usage of JH2 in D-J joinings with DQ52 is determined by the primary DNA sequence and is largely dependent on recombination signal sequencesEuropean Journal of Immunology, 1992
- Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.Journal of Clinical Investigation, 1992
- A strong propensity toward loop formation characterizes the expressed reading frames of the D segments at the Ig H and T cell receptor lociEuropean Journal of Immunology, 1991
- B cell development regulated by gene rearrangement: Arrest of maturation by membrane-bound Dμ protein and selection of DH element reading framesCell, 1991
- Early human IgH gene assembly in Epstein-Barr virus-transformed fetal B cell lines. Preferential utilization of the most JH-proximal D segment (DQ52) and two unusual VH-related rearrangements.The Journal of Experimental Medicine, 1989
- Immunoglobulin VH genes are transcribed by T cells in association with a new 5' exon.The Journal of Experimental Medicine, 1988
- A novel family of variable region genes of the human immunoglobulin heavy chainJournal of Molecular Biology, 1987
- Organization and evolution of variable region genes of the human immunoglobulin heavy chainJournal of Molecular Biology, 1986